LENZ Therapeutics Expected to Post 91-Cent Per-Share Loss
An earnings preview says LENZ Therapeutics is expected to post a loss of 91 cents per share.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.